Literature DB >> 19734601

Cryptosporidiosis in developing countries.

William J Snelling1, Lihua Xiao, Guadalupe Ortega-Pierres, Colm J Lowery, John E Moore, Juluri R Rao, Stephen Smyth, B Cherie Millar, Paul J Rooney, Motoo Matsuda, Fiona Kenny, Jiru Xu, James S G Dooley.   

Abstract

Globally, Cryptosporidium infection continues to be a significant health problem where it is recognized as an important cause of diarrhoea in both immunocompromised and immunocompetent people. In developing countries persistent diarrhoea is the leading cause of death in children younger than five years of age, where it accounts for 30 to 50 percent of those deaths. Encouragingly an increasing number of investigations in developing countries employ molecular tools, significantly improving the quality of epidemiological information. This improved Cryptosporidium monitoring, with appropriate molecular methods, in surface water, livestock, wildlife and humans, will increase current knowledge of infection and transmission patterns, and ultimately help to control Cryptosporidium via improved risk assessments in the future.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19734601

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  37 in total

1.  Systemic antibody responses to the immunodominant p23 antigen and p23 polymorphisms in children with cryptosporidiosis in Bangladesh.

Authors:  Anoli J Borad; Geneve M Allison; David Wang; Sabeena Ahmed; Mohammad M Karim; Anne V Kane; Joy Moy; Patricia L Hibberd; Sitara Swarna Rao Ajjampur; Gagandeep Kang; Stephen B Calderwood; Edward T Ryan; Elena Naumova; Wasif A Khan; Honorine D Ward
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

2.  Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis.

Authors:  Suresh Kumar Gorla; Nina N McNair; Guangyi Yang; Song Gao; Ming Hu; Venkatakrishna R Jala; Bodduluri Haribabu; Boris Striepen; Gregory D Cuny; Jan R Mead; Lizbeth Hedstrom
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

3.  Apicomplexan lineage-specific polytopic membrane proteins in Cryptosporidium parvum.

Authors:  Thavamani Rajapandi
Journal:  J Parasit Dis       Date:  2020-03-13

4.  Risk factors for cryptosporidiosis among children in a semi urban slum in southern India: a nested case-control study.

Authors:  Rajiv Sarkar; Deepthi Kattula; Mark R Francis; Sitara S R Ajjampur; Ashok D Prabakaran; Nithya Jayavelu; Jayaprakash Muliyil; Vinohar Balraj; Elena N Naumova; Honorine D Ward; Gagandeep Kang
Journal:  Am J Trop Med Hyg       Date:  2014-10-20       Impact factor: 2.345

5.  Giardia Infection and Trypanosoma Cruzi Exposure in Dogs in the Bosawás Biosphere Reserve, Nicaragua.

Authors:  Amber F Roegner; Miles E Daniels; Woutrina A Smith; Nicole Gottdenker; Laura M Schwartz; James Liu; Amanda Campbell; Christine V Fiorello
Journal:  Ecohealth       Date:  2019-08-14       Impact factor: 3.184

6.  In silico identification and validation of a novel hypothetical protein in Cryptosporidium hominis and virtual screening of inhibitors as therapeutics.

Authors:  Arpit Kumar Shrivastava; Subrat Kumar; Priyadarshi Soumyaranjan Sahu; Rajani Kanta Mahapatra
Journal:  Parasitol Res       Date:  2017-04-07       Impact factor: 2.289

Review 7.  Human cryptosporidiosis in Iran: a systematic review and meta-analysis.

Authors:  Reza Berahmat; Adel Spotin; Ehsan Ahmadpour; Mahmoud Mahami-Oskouei; Azim Rezamand; Nayyereh Aminisani; Morteza Ghojazadeh; Roghayeh Ghoyounchi; Tahereh Mikaeili-Galeh
Journal:  Parasitol Res       Date:  2017-01-21       Impact factor: 2.289

8.  Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth.

Authors:  Kovi Bessoff; Adam Sateriale; K Kyungae Lee; Christopher D Huston
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

9.  Cryptosporidium and Strongyloides stercoralis infections among people with and without HIV infection and efficiency of diagnostic methods for Strongyloides in Yirgalem Hospital, southern Ethiopia.

Authors:  Amde Getaneh; Girmay Medhin; Techalew Shimelis
Journal:  BMC Res Notes       Date:  2010-04-01

10.  Optimization of benzoxazole-based inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.

Authors:  Suresh Kumar Gorla; Mandapati Kavitha; Minjia Zhang; James En Wai Chin; Xiaoping Liu; Boris Striepen; Magdalena Makowska-Grzyska; Youngchang Kim; Andrzej Joachimiak; Lizbeth Hedstrom; Gregory D Cuny
Journal:  J Med Chem       Date:  2013-05-13       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.